1-9 of 9
Sort by
News

Durable Efficacy With LOXO-305 in Heavily Pretreated CLL/SLL

Published: 2021
View News titled, Durable Efficacy With LOXO-305 in Heavily Pretreated CLL/SLL
News

Predicting CAR T-Cell Treatment Failure in Patients With Aggressive B-Cell Lymphomas

Published: 2021
View News titled, Predicting CAR T-Cell Treatment Failure in Patients With Aggressive B-Cell Lymphomas
News

Moving Beyond Gene Rearrangements to Define High-Risk Diffuse Large B-Cell Lymphoma

Published: 2021
View News titled, Moving Beyond Gene Rearrangements to Define High-Risk Diffuse Large B-Cell Lymphoma
News

Evaluating Iberdomide Plus Daratumumab or Bortezomib in Relapsed/Refractory Myeloma

Published: 2021
View News titled, Evaluating Iberdomide Plus Daratumumab or Bortezomib in Relapsed/Refractory Myeloma
News

Charting the Myeloma Immunotherapy Landscape

Published: 2021
View News titled, Charting the Myeloma Immunotherapy Landscape
News

Use of Transplant Persists as Appropriate Option in PTCLs

Published: 2021
View News titled, Use of Transplant Persists as Appropriate Option in PTCLs
News

Researchers Validate Burkitt Lymphoma Prognostic Index

Published: 2021
View News titled, Researchers Validate Burkitt Lymphoma Prognostic Index
News

Idecabtagene Vicleucel Promising in Pretreated Myeloma

Published: 2021
View News titled, Idecabtagene Vicleucel Promising in Pretreated Myeloma
News

Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

Published: 2021
View News titled, Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL